Cost-effectiveness of methotrexate and Goeckerman therapy: a flawed analysis

Arch Dermatol. 1999 Jun;135(6):717-8. doi: 10.1001/archderm.135.6.717.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cost-Benefit Analysis
  • Dermatologic Agents / economics*
  • Dermatologic Agents / therapeutic use*
  • Humans
  • Methotrexate / economics*
  • Methotrexate / therapeutic use*
  • Psoriasis / therapy*
  • Ultraviolet Therapy / economics*

Substances

  • Dermatologic Agents
  • Methotrexate